Concepedia

Sonja Hager

SH

Statistics

Publications

18

Citations

728

H-Index

16

Active since

2016

Affiliations

Medical University of Vienna(Current)

University of Vienna

Comprehensive Cancer Center Vienna

University of Szeged

Semmelweis University

Sonja Hager is an author at Medical University of Vienna specializing in pharmacology, medicinal chemistry, and cancer pharmacology.

Publications per year

2016–2024

18

Publications

18

Copper-Catalyzed Glutathione Oxidation is Accelerated by the Anticancer Thiosemicarbazone Dp44mT and Further Boosted at Lower pH

Enrico Falcone, Alessandra Gilda Ritacca, Sonja Hager et al. · Journal of the American Chemical Society · 2022 · 76 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +16

The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition

Sonja Hager, Katharina Korbula, Bjoern Bielec et al. · Cell Death and Disease · 2018 · 74 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling

Zhengnan Cai, Li Wan, Sonja Hager et al. · Cellular and Molecular Immunology · 2024 · 72 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands

Philipp Fronik, Isabella Poetsch, Alexander Kastner et al. · Journal of Medicinal Chemistry · 2021 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux

Julia H. Bormio Nunes, Sonja Hager, Marlene Mathuber et al. · Journal of Medicinal Chemistry · 2020 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 18